Live Quote · NASDAQNBIXHealthcare· Biotechnology

Neurocrine Biosciences, Inc.

$150.57▼ 3.84%($-6.02)
MKT CAP $15.24BNEXT EARNINGS Feb 10, 2027
50%
Bullish
TickerSpark Score
89/100
▌ Strong
80
Valuation
95
Profitability
95
Growth
96
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NBIX research report →

Analyst Price Target
$203.41+35.1% vs. today

Range $165 – $225

Analyst RatingBuy
32 Buy5 Hold0 Sell

Price Chart

+8.34% · this period
$185.50$154.30$123.10Nov 20May 26Nov 20
52-Week Range44% of range
Low
$122.14
Current
$150.57
High
$186.12

AI analysis · Last refreshed November 17, 2026 · Live quote · Not investment advice